Serum brain natriuretic peptide for prediction of successful medical treatment of patent ductus arteriosus in premature infants

Journal of Thoracic and Cardiovascular Surgery

Volumn 138, Issue 1, 2009, Pages 261-262

  Ohashi, Atsushi ^a   Kaneko, Kazunari ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; INDOMETACIN;

CLINICAL ARTICLE; DISEASE SEVERITY; DOSE RESPONSE; ECHOCARDIOGRAPHY; HEMODYNAMICS; HUMAN; IMMUNOASSAY; INFANT; LETTER; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; TREATMENT RESPONSE;

DUCTUS ARTERIOSUS, PATENT; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; NATRIURETIC PEPTIDE, BRAIN;

EID: 67649390843     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.09.083     Document Type: Letter

References (5)

1. Tschuppert S., Doell C., Arlettaz-Mieth R., Baenziger O., Rousson V., Balmer C., et al. The effect of ductal diameter on surgical and medical closure of patent ductus arteriosus in preterm neonates: size matters. J Thorac Cardiovasc Surg 135 (2008) 78-82
2. Giardini A., and Derrick G. The effect of ductal diameter on surgical and medical closure of patent ductus arteriosus in preterm neonates. J Thorac Cardiovasc Surg 136 (2008) 240
3. Sanjeev S., Pettersen M., Lua J., Thomas R., Shankaran S., and L'Ecuyer T. Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates. J Perinatol 25 (2005) 709-713
4. Choi B.M., Lee K.H., Eun B.L., Yoo K.H., Hong Y.S., Son C.S., et al. Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics 115 (2005) 255-261
5. Puddy V.F., Amirmansour C., Williams A.F., and Singer D.R. Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants. Clin Sci 103 (2002) 75-77